Enanta Pharmaceuticals shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $214k | 18k | 11.98 |
| 2025-03-31 | $332k | 60k | 5.52 |
| 2024-12-31 | $177k | 31k | 5.76 |
| 2023-12-31 | $271k | 29k | 9.42 |
| 2023-09-30 | $258k | 23k | 11.19 |
| 2023-06-30 | $684k | 32k | 21.39 |
| 2023-03-31 | $1.6M | 39k | 40.45 |
| 2022-12-31 | $514k | 11k | 46.49 |
| 2021-06-30 | $276k | 6.3k | 43.94 |
| 2020-09-30 | $491k | 11k | 45.82 |
| 2020-06-30 | $207k | 4.1k | 50.10 |
| 2019-12-31 | $916k | 15k | 61.77 |
| 2019-09-30 | $287k | 4.8k | 60.05 |
| 2019-06-30 | $1.0M | 12k | 84.38 |
| 2019-03-31 | $1.5M | 15k | 95.52 |
| 2018-12-31 | $878k | 12k | 70.81 |
| 2018-09-30 | $1.3M | 15k | 85.46 |
| 2018-06-30 | $2.8M | 24k | 115.90 |
| 2018-03-31 | $469k | 5.8k | 80.86 |
| 2017-12-31 | $552k | 9.4k | 58.72 |
| 2017-09-30 | $922k | 20k | 46.80 |
| 2017-06-30 | $291k | 8.1k | 35.93 |
| 2016-12-31 | $2.6M | 77k | 33.50 |
| 2016-09-30 | $2.2M | 82k | 26.61 |
| 2016-06-30 | $3.0M | 137k | 22.05 |
| 2016-03-31 | $3.7M | 127k | 29.37 |
| 2015-12-31 | $2.7M | 80k | 33.02 |
| 2015-09-30 | $2.0M | 56k | 36.14 |
| 2015-06-30 | $2.4M | 53k | 44.98 |
| 2015-03-31 | $1.9M | 62k | 30.63 |
| 2014-12-31 | $366k | 7.2k | 50.83 |
| 2014-09-30 | $918k | 23k | 39.57 |